<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30760441</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>12</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1756-1833</ISSN><JournalIssue CitedMedium="Internet"><Volume>364</Volume><PubDate><Year>2019</Year><Month>Feb</Month><Day>13</Day></PubDate></JournalIssue><Title>BMJ (Clinical research ed.)</Title><ISOAbbreviation>BMJ</ISOAbbreviation></Journal><ArticleTitle>Enterovirus as trigger of coeliac disease: nested case-control study within prospective birth cohort.</ArticleTitle><Pagination><StartPage>l231</StartPage><MedlinePgn>l231</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">l231</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmj.l231</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To determine whether infection with human enterovirus or adenovirus, both common intestinal viruses, predicts development of coeliac disease.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Case-control study nested within Norwegian birth cohort recruited between 2001 and 2007 and followed to September 2016.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Norwegian population.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Children carrying the HLA genotype DR4-DQ8/DR3-DQ2 conferring increased risk of coeliac disease.</AbstractText><AbstractText Label="EXPOSURES" NlmCategory="METHODS">Enterovirus and adenovirus detected using real time polymerase chain reaction in monthly stool samples from age 3 to 36 months.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURE" NlmCategory="METHODS">Coeliac disease diagnosed according to standard criteria. Coeliac disease antibodies were tested in blood samples taken at age 3, 6, 9, and 12 months and then annually. Adjusted odds ratios from mixed effects logistic regression model were used to assess the relation between viral infections before development of coeliac disease antibodies and coeliac disease.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 220 children, and after a mean of 9.9 (SD 1.6) years, 25 children were diagnosed as having coeliac disease after screening and were matched to two controls each. Enterovirus was found in 370 (17%) of 2135 samples and was significantly more frequent in samples collected before development of coeliac disease antibodies in cases than in controls (adjusted odds ratio 1.49, 95% confidence interval 1.07 to 2.06; P=0.02). The association was restricted to infections after introduction of gluten. High quantity samples (&gt;100&#x2009;000 copies/&#x3bc;L) (adjusted odds ratio 2.11, 1.24 to 3.60; P=0.01) and long lasting infections (&gt;2 months) (2.16, 1.16 to 4.04; P=0.02) gave higher risk estimates. Both the commonly detected enterovirus species <i>Enterovirus A</i> and <i>Enterovirus B</i> were significantly associated with coeliac disease. The association was not found for infections during or after development of coeliac disease antibodies. Adenovirus was not associated with coeliac disease.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In this longitudinal study, a higher frequency of enterovirus, but not adenovirus, during early childhood was associated with later coeliac disease. The finding adds new information on the role of viral infections in the aetiology of coeliac disease.</AbstractText><CopyrightInformation>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kahrs</LastName><ForeName>Christian R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, &#xd8;stfold Hospital Trust, Gr&#xe5;lum, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Norwegian Institute of Public Health, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chuda</LastName><ForeName>Katerina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tapia</LastName><ForeName>German</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Norwegian Institute of Public Health, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stene</LastName><ForeName>Lars C</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Norwegian Institute of Public Health, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xe5;rild</LastName><ForeName>Karl</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Institute of Clinical Sciences, The Sahlgrenska Academy at University of Gothenburg and Queen Silvia Children's Hospital, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasmussen</LastName><ForeName>Trond</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of IT and e-health, Division of Institute Resources, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>R&#xf8;nningen</LastName><ForeName>Kjersti S</ForeName><Initials>KS</Initials><AffiliationInfo><Affiliation>Department of Pediatric Research, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lundin</LastName><ForeName>Knut E A</ForeName><Initials>KEA</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Oslo University Hospital Rikshospitalet, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>K.G. Jebsen Coeliac Disease Research Centre, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kramna</LastName><ForeName>Lenka</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cinek</LastName><ForeName>Ondrej</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>St&#xf8;rdal</LastName><ForeName>Ketil</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-7826-8646</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, &#xd8;stfold Hospital Trust, Gr&#xe5;lum, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Norwegian Institute of Public Health, Oslo, Norway.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>02</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ</MedlineTA><NlmUniqueID>8900488</NlmUniqueID><ISSNLinking>0959-8138</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002446" MajorTopicYN="N">Celiac Disease</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005243" MajorTopicYN="N">Feces</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009664" MajorTopicYN="N" Type="Geographic">Norway</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060888" MajorTopicYN="N">Real-Time Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work other than that described above; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30760441</ArticleId><ArticleId IdType="pmc">PMC6372922</ArticleId><ArticleId IdType="doi">10.1136/bmj.l231</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Green PH, Cellier C. Celiac disease. N Engl J Med 2007;357:1731-43. 10.1056/NEJMra071600&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra071600</ArticleId><ArticleId IdType="pubmed">17960014</ArticleId></ArticleIdList></Reference><Reference><Citation>Romanos J, Ros&#xe9;n A, Kumar V, et al. PreventCD Group Improving coeliac disease risk prediction by testing non-HLA variants additional to HLA variants. Gut 2014;63:415-22. 10.1136/gutjnl-2012-304110&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2012-304110</ArticleId><ArticleId IdType="pmc">PMC3933173</ArticleId><ArticleId IdType="pubmed">23704318</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe5;rild K, Vistnes M, Tapia G, et al. Midpregnancy and cord blood immunologic biomarkers, HLA genotype, and pediatric celiac disease. J Allergy Clin Immunol 2017;139:1696-8. 10.1016/j.jaci.2016.10.016&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2016.10.016</ArticleId><ArticleId IdType="pubmed">27865861</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu E, Lee HS, Aronsson CA, et al. TEDDY Study Group Risk of pediatric celiac disease according to HLA haplotype and country. N Engl J Med 2014;371:42-9. 10.1056/NEJMoa1313977&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1313977</ArticleId><ArticleId IdType="pmc">PMC4163840</ArticleId><ArticleId IdType="pubmed">24988556</ArticleId></ArticleIdList></Reference><Reference><Citation>Agardh D, Lee HS, Kurppa K, et al. TEDDY Study Group Clinical features of celiac disease: a prospective birth cohort. Pediatrics 2015;135:627-34. 10.1542/peds.2014-3675&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2014-3675</ArticleId><ArticleId IdType="pmc">PMC4379464</ArticleId><ArticleId IdType="pubmed">25733751</ArticleId></ArticleIdList></Reference><Reference><Citation>Abadie V, Sollid LM, Barreiro LB, Jabri B. Integration of genetic and immunological insights into a model of celiac disease pathogenesis. Annu Rev Immunol 2011;29:493-525. 10.1146/annurev-immunol-040210-092915&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-040210-092915</ArticleId><ArticleId IdType="pubmed">21219178</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe5;rild K, Kahrs CR, Tapia G, Stene LC, St&#xf8;rdal K. Infections and risk of celiac disease in childhood: a prospective nationwide cohort study. Am J Gastroenterol 2015;110:1475-84. 10.1038/ajg.2015.287&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ajg.2015.287</ArticleId><ArticleId IdType="pubmed">26346866</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemppainen KM, Lynch KF, Liu E, et al. TEDDY Study Group Factors That Increase Risk of Celiac Disease Autoimmunity After a Gastrointestinal Infection in Early Life. Clin Gastroenterol Hepatol 2017;15:694-702.e5. 10.1016/j.cgh.2016.10.033&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2016.10.033</ArticleId><ArticleId IdType="pmc">PMC5576726</ArticleId><ArticleId IdType="pubmed">27840181</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouziat R, Hinterleitner R, Brown JJ, et al. Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease. Science 2017;356:44-50. 10.1126/science.aah5298&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aah5298</ArticleId><ArticleId IdType="pmc">PMC5506690</ArticleId><ArticleId IdType="pubmed">28386004</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb A, Starr M. Acute gastroenteritis in children. Aust Fam Physician 2005;34:227-31.</Citation><ArticleIdList><ArticleId IdType="pubmed">15861741</ArticleId></ArticleIdList></Reference><Reference><Citation>Schumann M, Siegmund B, Schulzke JD, Fromm M. Celiac Disease: Role of the Epithelial Barrier. Cell Mol Gastroenterol Hepatol 2017;3:150-62. 10.1016/j.jcmgh.2016.12.006&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmgh.2016.12.006</ArticleId><ArticleId IdType="pmc">PMC5331784</ArticleId><ArticleId IdType="pubmed">28275682</ArticleId></ArticleIdList></Reference><Reference><Citation>Stene LC, Honeyman MC, Hoffenberg EJ, et al. Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am J Gastroenterol 2006;101:2333-40. 10.1111/j.1572-0241.2006.00741.x&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1572-0241.2006.00741.x</ArticleId><ArticleId IdType="pubmed">17032199</ArticleId></ArticleIdList></Reference><Reference><Citation>Kagnoff MF, Paterson YJ, Kumar PJ, et al. Evidence for the role of a human intestinal adenovirus in the pathogenesis of coeliac disease. Gut 1987;28:995-1001. 10.1136/gut.28.8.995&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.28.8.995</ArticleId><ArticleId IdType="pmc">PMC1433141</ArticleId><ArticleId IdType="pubmed">2822550</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahon J, Blair GE, Wood GM, Scott BB, Losowsky MS, Howdle PD. Is persistent adenovirus 12 infection involved in coeliac disease? A search for viral DNA using the polymerase chain reaction. Gut 1991;32:1114-6. 10.1136/gut.32.10.1114&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.32.10.1114</ArticleId><ArticleId IdType="pmc">PMC1379369</ArticleId><ArticleId IdType="pubmed">1955164</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercalli A, Lampasona V, Klingel K, et al. No evidence of enteroviruses in the intestine of patients with type 1 diabetes. Diabetologia 2012;55:2479-88. 10.1007/s00125-012-2591-4&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-012-2591-4</ArticleId><ArticleId IdType="pubmed">22684312</ArticleId></ArticleIdList></Reference><Reference><Citation>Stene LC, Wits&#xf8; E, Torjesen PA, et al. Islet autoantibody development during follow-up of high-risk children from the general Norwegian population from three months of age: design and early results from the MIDIA study. J Autoimmun 2007;29:44-51. 10.1016/j.jaut.2007.04.003&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2007.04.003</ArticleId><ArticleId IdType="pubmed">17560077</ArticleId></ArticleIdList></Reference><Reference><Citation>Cinek O, Wits&#xf8; E, Jeansson S, et al. Longitudinal observation of enterovirus and adenovirus in stool samples from Norwegian infants with the highest genetic risk of type 1 diabetes. J Clin Virol 2006;35:33-40. 10.1016/j.jcv.2005.03.007&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2005.03.007</ArticleId><ArticleId IdType="pubmed">15916916</ArticleId></ArticleIdList></Reference><Reference><Citation>Husby S, Koletzko S, Korponay-Szab&#xf3; IR, et al. ESPGHAN Working Group on Coeliac Disease Diagnosis. ESPGHAN Gastroenterology Committee. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012;54:136-60. 10.1097/MPG.0b013e31821a23d0&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MPG.0b013e31821a23d0</ArticleId><ArticleId IdType="pubmed">22197856</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xfc;rgin-Wolff A, Gaze H, Hadziselimovic F, et al. Antigliadin and antiendomysium antibody determination for coeliac disease. Arch Dis Child 1991;66:941-7. 10.1136/adc.66.8.941&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/adc.66.8.941</ArticleId><ArticleId IdType="pmc">PMC1793455</ArticleId><ArticleId IdType="pubmed">1819255</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xfc;rgin-Wolff A, Dahlbom I, Hadziselimovic F, Petersson CJ. Antibodies against human tissue transglutaminase and endomysium in diagnosing and monitoring coeliac disease. Scand J Gastroenterol 2002;37:685-91. 10.1080/00365520212496&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00365520212496</ArticleId><ArticleId IdType="pubmed">12126247</ArticleId></ArticleIdList></Reference><Reference><Citation>Arguelles-Grande C, Norman GL, Bhagat G, Green PH. Hemolysis interferes with the detection of anti-tissue transglutaminase antibodies in celiac disease. Clin Chem 2010;56:1034-6. 10.1373/clinchem.2009.141242&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1373/clinchem.2009.141242</ArticleId><ArticleId IdType="pubmed">20224046</ArticleId></ArticleIdList></Reference><Reference><Citation>Myl&#xe9;us A, Ivarsson A, Webb C, et al. Celiac disease revealed in 3% of Swedish 12-year-olds born during an epidemic. J Pediatr Gastroenterol Nutr 2009;49:170-6. 10.1097/MPG.0b013e31818c52cc&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MPG.0b013e31818c52cc</ArticleId><ArticleId IdType="pubmed">19516192</ArticleId></ArticleIdList></Reference><Reference><Citation>Honkanen H, Oikarinen S, Pakkanen O, et al. Human enterovirus 71 strains in the background population and in hospital patients in Finland. J Clin Virol 2013;56:348-53. 10.1016/j.jcv.2012.11.018&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2012.11.018</ArticleId><ArticleId IdType="pubmed">23261080</ArticleId></ArticleIdList></Reference><Reference><Citation>Claas EC, Schilham MW, de Brouwer CS, et al. Internally controlled real-time PCR monitoring of adenovirus DNA load in serum or plasma of transplant recipients. J Clin Microbiol 2005;43:1738-44. 10.1128/JCM.43.4.1738-1744.2005&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.43.4.1738-1744.2005</ArticleId><ArticleId IdType="pmc">PMC1081334</ArticleId><ArticleId IdType="pubmed">15814994</ArticleId></ArticleIdList></Reference><Reference><Citation>Cinek O, Kramna L, Mazankova K, et al. Virus genotyping by massive parallel amplicon sequencing: adenovirus and enterovirus in the Norwegian MIDIA study. J Med Virol 2018;10: [Epub ahead of print]. 10.1002/jmv.25361.&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25361</ArticleId><ArticleId IdType="pubmed">30537228</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapia G, Cinek O, Rasmussen T, et al. Human enterovirus RNA in monthly fecal samples and islet autoimmunity in Norwegian children with high genetic risk for type 1 diabetes: the MIDIA study. Diabetes Care 2011;34:151-5. 10.2337/dc10-1413&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc10-1413</ArticleId><ArticleId IdType="pmc">PMC3005474</ArticleId><ArticleId IdType="pubmed">20929993</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J, Thibaut HJ, Strating JRPM, van Kuppeveld FJM. Publisher Correction: The life cycle of non-polio enteroviruses and how to target it. Nat Rev Microbiol 2018;16:391. 10.1038/s41579-018-0022-3&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-018-0022-3</ArticleId><ArticleId IdType="pubmed">29725113</ArticleId></ArticleIdList></Reference><Reference><Citation>Pallansch MA, Roos RP. Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. In: Knipe DM, Howley PM, eds. Fields Virology. 7th ed Lippincott Williams &amp;Wilkins, 2007: 839-94.</Citation></Reference><Reference><Citation>Wits&#xf8; E, Palacios G, Cinek O, et al. High prevalence of human enterovirus a infections in natural circulation of human enteroviruses. J Clin Microbiol 2006;44:4095-100. 10.1128/JCM.00653-06&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00653-06</ArticleId><ArticleId IdType="pmc">PMC1698346</ArticleId><ArticleId IdType="pubmed">16943351</ArticleId></ArticleIdList></Reference><Reference><Citation>Viskari H, Oikarinen S, Hoppu S, et al. Live attenuated enterovirus vaccine (OPV) is not associated with islet autoimmunity in children with genetic susceptibility to type 1 diabetes: prospective cohort study. Diabetologia 2018;61:203-9. 10.1007/s00125-017-4410-4&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-017-4410-4</ArticleId><ArticleId IdType="pubmed">28866779</ArticleId></ArticleIdList></Reference><Reference><Citation>Norwegian Institute of Public Health. Vaksinasjonsveilederen for helsepersonell (information about the norwegian vaccine program). 2017 [cited 6 February 2018]. https://www.fhi.no/nettpub/vaksinasjonsveilederen-for-helsepersonell/vaksiner-mot-de-enkelte-sykdommene/poliovaksinasjon-poliomyelitt---vei/.</Citation></Reference><Reference><Citation>Nilsen RM, Vollset SE, Gjessing HK, et al. Self-selection and bias in a large prospective pregnancy cohort in Norway. Paediatr Perinat Epidemiol 2009;23:597-608. 10.1111/j.1365-3016.2009.01062.x&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-3016.2009.01062.x</ArticleId><ArticleId IdType="pubmed">19840297</ArticleId></ArticleIdList></Reference><Reference><Citation>Wits&#xf8; E, Cinek O, Aldrin M, et al. Predictors of sub-clinical enterovirus infections in infants: a prospective cohort study. Int J Epidemiol 2010;39:459-68. 10.1093/ije/dyp333&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyp333</ArticleId><ArticleId IdType="pubmed">19939809</ArticleId></ArticleIdList></Reference><Reference><Citation>Oikarinen M, Tauriainen S, Oikarinen S, et al. Type 1 diabetes is associated with enterovirus infection in gut mucosa. Diabetes 2012;61:687-91. 10.2337/db11-1157&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db11-1157</ArticleId><ArticleId IdType="pmc">PMC3282798</ArticleId><ArticleId IdType="pubmed">22315304</ArticleId></ArticleIdList></Reference><Reference><Citation>Honkanen H, Oikarinen S, Nurminen N, et al. Detection of enteroviruses in stools precedes islet autoimmunity by several months: possible evidence for slowly operating mechanisms in virus-induced autoimmunity. Diabetologia 2017;60:424-31. 10.1007/s00125-016-4177-z&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-016-4177-z</ArticleId><ArticleId IdType="pubmed">28070615</ArticleId></ArticleIdList></Reference><Reference><Citation>Krogvold L, Edwin B, Buanes T, et al. Detection of a low-grade enteroviral infection in the islets of langerhans of living patients newly diagnosed with type 1 diabetes. Diabetes 2015;64:1682-7. 10.2337/db14-1370&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db14-1370</ArticleId><ArticleId IdType="pubmed">25422108</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapia G, Cinek O, Rasmussen T, et al. Human enterovirus RNA in monthly fecal samples and islet autoimmunity in Norwegian children with high genetic risk for type 1 diabetes: the MIDIA study. Diabetes Care 2011;34:151-5. 10.2337/dc10-1413&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc10-1413</ArticleId><ArticleId IdType="pmc">PMC3005474</ArticleId><ArticleId IdType="pubmed">20929993</ArticleId></ArticleIdList></Reference><Reference><Citation>Kagnoff MF, Austin RK, Hubert JJ, Bernardin JE, Kasarda DD. Possible role for a human adenovirus in the pathogenesis of celiac disease. J Exp Med 1984;160:1544-57. 10.1084/jem.160.5.1544&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.160.5.1544</ArticleId><ArticleId IdType="pmc">PMC2187489</ArticleId><ArticleId IdType="pubmed">6491604</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xe4;hdeaho ML, Parkkonen P, Reunala T, M&#xe4;ki M, Lehtinen M. Antibodies to E1b protein-derived peptides of enteric adenovirus type 40 are associated with celiac disease and dermatitis herpetiformis. Clin Immunol Immunopathol 1993;69:300-5. 10.1006/clin.1993.1184&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/clin.1993.1184</ArticleId><ArticleId IdType="pubmed">7694817</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawler M, Humphries P, O&#x2019;Farrelly C, et al. Adenovirus 12 E1A gene detection by polymerase chain reaction in both the normal and coeliac duodenum. Gut 1994;35:1226-32. 10.1136/gut.35.9.1226&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.35.9.1226</ArticleId><ArticleId IdType="pmc">PMC1375698</ArticleId><ArticleId IdType="pubmed">7959228</ArticleId></ArticleIdList></Reference><Reference><Citation>Schumann M, Siegmund B, Schulzke JD, Fromm M. Celiac disease: role of the epithelial barrier. Cell Mol Gastroenterol Hepatol 2017;3:150-62. 10.1016/j.jcmgh.2016.12.006&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmgh.2016.12.006</ArticleId><ArticleId IdType="pmc">PMC5331784</ArticleId><ArticleId IdType="pubmed">28275682</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollid LM, Jabri B. Triggers and drivers of autoimmunity: lessons from coeliac disease. Nat Rev Immunol 2013;13:294-302. 10.1038/nri3407&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3407</ArticleId><ArticleId IdType="pmc">PMC3818716</ArticleId><ArticleId IdType="pubmed">23493116</ArticleId></ArticleIdList></Reference><Reference><Citation>Matzinger P. The danger model: a renewed sense of self. Science 2002;296:301-5. 10.1126/science.1071059&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1071059</ArticleId><ArticleId IdType="pubmed">11951032</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone VM, Hankaniemi MM, Svedin E, et al. A Coxsackievirus B vaccine protects against virus-induced diabetes in an experimental mouse model of type 1 diabetes. Diabetologia 2018;61:476-81. 10.1007/s00125-017-4492-z&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-017-4492-z</ArticleId><ArticleId IdType="pmc">PMC6448957</ArticleId><ArticleId IdType="pubmed">29151123</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>